Uncovering molecular events associated with the chemosuppressive effects of flaxseed: a microarray analysis of the laying hen model of ovarian cancer by unknown
Hales et al. BMC Genomics 2014, 15:709
http://www.biomedcentral.com/1471-2164/15/709RESEARCH ARTICLE Open AccessUncovering molecular events associated with the
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Background: The laying hen model of spontaneous epithelial ovarian cancer (EOC) is unique in that it is the only
model that enables observations of early events in disease progression and is therefore also uniquely suited for
chemoprevention trials. Previous studies on the effect of dietary flaxseed in laying hens have revealed the potential
for both amelioration and prevention of ovarian cancer. The objective of this study was to assess the effect of
flaxseed on genes and pathways that are dysregulated in tumors. We have used a bioinformatics approach to
identify these genes, followed by qPCR validation, immunohistochemical localization, and in situ hybridization to
visualize expression in normal ovaries and tumors from animals fed a control diet or a diet containing 10% flaxseed.
Results: Bioinformatic analysis of ovarian tumors in hens led to the identification of a group of highly up-regulated
genes that are involved in the embryonic process of branching morphogenesis. Expression of these genes coincides
with expression of E-cadherin in the tumor epithelium. Levels of expression of these genes in tumors from flax-fed
animals are reduced 40-60%. E-cadherin and miR200 are both up-regulated in tumors from control-fed hens,
whereas their expression is decreased 60-75% in tumors from flax-fed hens. This does not appear to be due to
an increase in ZEB1 as mRNA levels are increased five-fold in tumors, with no significant difference between
control-fed and flax-fed hens.
Conclusions: We suggest that nutritional intervention with flaxseed targets the pathways regulating branching
morphogenesis and thereby alters the progression of ovarian cancer.
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One out of 71 women will develop ovarian cancer in her
lifetime. The five year survival rate is less than 44%,
making ovarian cancer the most lethal gynecologic ma-
lignancy. This number has not changed significantly in
the last 20 years in spite of advances in platinum-based
chemotherapy [1]. For this reason, there is a critical need
to explore effective chemoprevention strategies.
It has been estimated that at least 30% of all cancers
could be prevented through diet, exercise, and main-
taining a healthy weight [2]. One outcome of this* Correspondence: khales@siumed.edu
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unless otherwise stated.approach is the reduction of the chronic, low-grade sys-
temic inflammation that accompanies obesity. Chronic in-
flammation has been implicated to play a causative role in
many diseases, including cancer [3]. Further reduction of
inflammation can be achieved by lowering the ratio of
omega-6 to omega-3 fatty acids. The modern western diet
contains a high ratio of omega-6 to omega-3 fatty acids, a
profile that is both pro-inflammatory and oxidant-rich
and creates an environment conducive to the develop-
ment of disease. Flaxseed is one of the richest plant
sources of omega-3 fatty acids. In addition, flaxseed also
contains lignans, a class of phytoestrogens that also act as
antioxidants [4]. These two different nutriceuticals have
pathway-specific actions, targeting inflammation and
oxidative damage.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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limited by the lack of suitable animal models. The laying
hen is a robust model in that ovarian cancer develops
spontaneously with pathological and histological presen-
tation very similar to human disease [5,6]. As in women,
the average age of onset occurs later in reproductive life,
with 40% of hens having the disease by six years of age
[7]. The disease can progress rapidly, with transcoelomic
spread disseminating from the ovary to organs and peri-
toneal surfaces, and with the accumulation of ascites.
The four histotypes observed in human are represented
in the hen, although the endometrioid type is the pre-
dominant form found in the hen whereas the serous
type is most prevalent in women [8]. Mutations in p53
are common in epithelial ovarian cancer (EOC) from
both species [9]. Numerous characteristic markers are
also shared between the tumors of the two species such
as CA-125 [10], CYP1B1 [11], E-cadherin [12] and
COX-1 [13]. The expression of COX-1 and accompa-
nying high levels of prostaglandin E2 presents a target
for dietary intervention with omega-3 fatty acids. Our
one year study of hens fed a diet of 10% flaxseed showed
reduction in cancer severity that corresponded to a re-
duction in prostaglandin levels [14]. This suggests that
ovarian cancer progression may be driven by inflamma-
tion. Our long term study in which hens were fed a diet
supplemented with 10% flaxseed for four years resulted
in a significant decrease in both incidence and severity
of ovarian cancer [15]. This suggests that in addition to
decreased progression, initiation and/or promotion of
this disease may be slowed by some component of flax-
seed. This data is dually important in that it highlights
the utility of the hen model for use in dietary studies of
chemoprevention, and it provides strong evidence that
dietary flaxseed significantly affects the initiation, pro-
motion and progression of ovarian cancer. Thus, identi-
fication of the pathways altered by flaxseed may give
insight into the etiology of the disease.
The objective of the current study was to identify pos-
sible targets and pathways affected by dietary flaxseed
and by ovarian cancer to determine the mechanisms by
which flaxseed confers chemoprotection against ovarian
cancer. We performed a microarray analysis which com-
pared normal ovaries and ovarian tumors from hens fed
a control diet to those of hens fed a diet supplemented
with 10% flaxseed. Microarray analysis was followed by
comprehensive bioinformatics and several levels of
experimental validation. This analysis revealed that
pathways associated with branching morphogenesis are
significantly increased in ovarian cancer and reduced by
flaxseed, suggesting that the process driving tumor
growth and progression toward a glandular morphology
are targeted by the biologically active constituents of
flaxseed.Results and discussion
Flaxseed modulates genes linked to ovarian cancer in the
laying hen
To evaluate the genome-wide effect of flaxseed in ovar-
ian cancer, we conducted microarray and bioinformatics
analyses. The Agilent custom 4x44K chicken long oligo
microarray [16] was utilized for this study based on 2X2
experimental conditions, i.e. diet (control & flaxseed
enriched) and tissue (normal & cancer). The samples
were obtained from the one year flaxseed study [14]. We
performed a 6-way pair analysis of the gene list between
the following groups: 1. Control Cancer (CC) to Control
Normal (CN); 2. Control Cancer to Flax Normal (FN); 3.
Flax Normal to Flax Cancer (FC); 4. Flax Cancer to Con-
trol Normal; 5. Control Normal to Flax Normal; 6. Flax
Cancer to Control Cancer (Figure 1). The gene ex-
pression pattern in each analysis group is distinct and
separates one group expression pattern from another,
suggesting the effect of flaxseed is diverse at the gene
level (Figure 2). This result encouraged us to focus on
specific sets of genes which are linked to cancer progres-
sion. Annotated genes used in the 4X44K arrays were
classified based on their biological and molecular path-
ways using a pathway analysis tool which yielded 337
genes (list of genes in Additional file 1) related to the
pathogenesis of ovarian cancer [17]. Further, we mea-
sured the expression of these 337 genes in the CC, CN,
FN, & FC groups and pair wise analyses were carried out
between the groups (Figure 2). Comparing the expres-
sion in different sample groups suggests that the group
fed with flaxseed downregulated cancer promoting path-
ways such as angiogenesis, VEGF signaling, endothelin
signaling, WNT signaling, cadherin signaling, inflamma-
tion and oxidative stress signaling. Similarly, tumor sup-
pressor pathways such as p53 signaling, apoptosis
signaling, cell cycle, and JAK/STAT signaling were up-
regulated, indicating that the flaxseed acts as an overall
tumor suppressor by negatively regulating the ovarian
cancer associated pathways and promoting tumor sup-
pressor pathways.
Microarray identification of genes responsive to flaxseed
In order to identify the genes which may be directly
linked with ovarian cancer progression, a comparison
was made of all cancer groups (control cancer and flax
cancer) to all normal groups (control normal and flax
normal) i.e. CC-CN to FC-FN, CC-CN to FC-CN and
FC-FN to CC-FN. This exercise generated 324 upregu-
lated genes and 287 downregulated genes which were
common in both cancer groups (control cancer and flax
cancer), indicating that their differential expression may
be involved in ovarian cancer pathogenesis (Figure 3). In
order to examine the flaxseed responsive genes, we
filtered and sorted a list of 118 genes (see material &
Figure 1 Diagrammatic representation of microarray experimental design. Based on 2X2 experimental conditions i.e. diet (control &
Flaxseed enriched) and tissue (normal & cancer) 44 k arrays were designed. The arrow represents Cy3; the end of the arrow represents Cy5.
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volved in ovarian cancer and may be targets of flaxseed.
Further examination of the expression levels of these
118 genes in CC-CN and FN-CN (Additional file 2) re-
vealed that there is differential expression between the
groups. The genes exhibit a difference in magnitude of
expression (fold change), indicating that the degree of
difference in expression is crucial for cancer progression
(Figure 3). Genes that are upregulated in cancer are also
increased in tumors from flax-fed animals but not to the
same extent. This is in agreement with earlier observa-
tions demonstrating that the expression of certain genes
above a critical threshold plays a protective role against
carcinogenesis but their aberrant expression beyond this
critical level may have an adverse effect [18]. Compari-
son of 118 genes between flax-normal vs. control-cancer
showed that most of these genes have significant dif-
ferences in their expression levels.
Real time PCR validation corroborates flaxseed responsive
genes found by microarray analysis
To validate our microarray analysis, we evaluated the
mRNA levels of 44 genes by PCR-array. These were re-
presentative genes identified by pathway analysis to be in-
volved in angiogenesis, signaling (wnt, integrin, cadherin,
JAK/STAT, Notch, VEGF pathways), cell cycle, apoptosis,
inflammation, oxidative stress and developmental path-
ways (Table 1). Figure 4 shows the expression of 22 genes
in each sample group. The level of gene expression of
these genes quantified by qPCR significantly matches withthe array results (not shown). Of the 22 genes not shown,
four are the house keeping genes used for normalization,
five were selected for further validation, and 13 were not
significantly different between groups. One of the impor-
tant observations of the study was that the well-
established cancer promoting and inflammatory genes like
IL2, VEGF1, IGF1, PTGS1, cMYC and CCDN1 [19] were
modulated by flaxseed compared to control-fed hens. Re-
duction in the expression of these inflammatory genes
suggests that flaxseed mitigates cancer promoting acti-
vities and acts as an anticancer agent. Stemness-associated
genes KLF4, OCT4 and SOX2 [20] were also analyzed.
SOX2, KLF4 and OCT4 were elevated in tumors from
control-fed hens. However, in tumors from flax-fed hens,
only SOX2 was greatly reduced whereas both KLF4 and
OCT4 expression was enhanced. Thus, flaxseed did not
have a uniform effect on the expression of genes asso-
ciated with stem cells.
E-cadherin, PAX2, MSX2, FOXA2 and Engrailed-1 are
upregulated in hen ovarian cancer and decreased by
dietary flaxseed
The gene that showed the greatest induction by the
microarray analysis was E-cadherin, with a 44-fold
increase in tumors compared to normal ovary. Up-
regulation of E-cadherin expression is one of the earliest
events in the development of EOC and is common to all
ovarian cancer histotypes [21]. This E-cadherin pattern
could potentially have diagnostic value, but more im-
portantly, identifying factors that regulate E-cadherin
Figure 2 Microarray analysis showing the effects of flaxseed in ovarian cancer at whole genome level. Left, chicken whole genome wide
heat map expression pattern at global level: All the gene probes used in the array which showed detectable level of expression during analysis were
visualized using heat map to show their differential expression levels between the groups i.e. control-cancer vs. control-normal, control-cancer vs.
flax-normal, control-cancer vs. flax-cancer, flax-cancer vs. flax-normal, flax-cancer vs. control normal and flax-normal vs. control normal. Right, heat map
visualization of pathway associated genes: Genes representing the specific biological pathway involved in cancer progression were sorted and their
expression levels were examined between the different analysis group and a heat map was generated for visualization.
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pathways become dysregulated very early on during the
transformation of normal cells toward a malignant phe-
notype. We have shown previously that E-cadherin is
significantly upregulated in hen ovarian cancer similar to
what is observed in the human disease [12]. qPCR ana-
lysis from the current study reveals that E-cadherin
mRNA is decreased more than 40% in tumors from hens
fed flaxseed (Figure 5) and E-cadherin protein has been
shown to be decreased by 50% in tumors from flax-fed
hens [22]. E-cadherin is expressed in the ovarian surface
epithelium (OSE) and expression in the tumor com-
partment is confined to the glandular epithelial cells
(Figure 6). The observation that flaxseed decreases
E-cadherin in ovarian cancer reveals that flaxseed modu-
lates very early events in neoplastic transformation.
The microarray analysis and PCR array identified an
additional group of genes that were upregulated in can-
cer and targeted by flaxseed. These were genes encoding
transcription factors involved in early development, cell-
fate determination and morphogenesis including PAX2[23], FOXA2 [24], MSX2 [25] and EN1 [26]. The expres-
sion of these genes was assayed in samples obtained
from the five year study (Figure 5) [15]. In agreement
with data from both human [27] and chicken [28], we
find PAX2 expression is upregulated 9-fold in ovarian
cancer from control-fed hens compared to normal ovar-
ies from control-fed hens. Additionally, we show that
flaxseed attenuated this upregulation in ovarian tumors
to 6-fold compared to normal ovaries. MSX2, a member
of the muscle segment homeobox family, is upregulated
5-fold in ovarian tumors from control-fed hens com-
pared to normal ovaries. Dietary flaxseed significantly
decreased this upregulation to 2-fold in ovarian tumors.
FOXA2 mRNA is aberrantly over-expressed 7-fold in
ovarian tumors from control-fed hens. This upregulation
is decreased by flaxseed to 4-fold in ovarian tumors
compared to normal ovaries. Lastly, we show that tu-
mors from control-fed hens exhibit a 6-fold upregulation
of EN1 mRNA compared to normal ovaries, and this up-
regulation is decreased by flaxseed to 2-fold compared
to normal ovaries. In addition, the flaxseed diet has an
Figure 3 Analysis of genes affected by cancer and diet. Left, changes in the expression of sorted genes between flax-normal vs. control-cancer
(FN-CC) was visualized by heat map. Right, Venn diagram of overlapping genes among the different data sets viz. control-cancer vs. control-normal
(CC-CN), flax-cancer vs. flax-normal (FC-FN) and flax-normal vs. control-normal (FN-CN) dataset. Genes are listed in additional file 2.
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E-cadherin mRNA in normal ovaries in the absence of
pathology. That all of these genes are significantly down-
regulated in tumors from flax-fed hens suggests that
they may play a role in the progression of the disease.
Immunohistochemical localization of PAX2, FOXA2
and EN1 reveals that they co-localize with E-cadherin in
the glandular epithelial compartment of the ovarian
tumor (Figure 6). No expression of these factors can be
detected prior to the expression of E-cadherin in the
cortical region of the ovary, nor do they co-localize with
E-cadherin in the OSE. Three of these genes play an
active role in normal gland morphogenesis. In the
mouse, PAX2 protein is required for Mullerian duct for-
mation, including ductal and mesenchymal elements
[23]. MSX2 expression has been reported to be increasedin human ovarian endometrioid adenocarcinoma as a
target of WNT signaling [29]. It has also been shown to
play a role in branching morphogenesis during mouse
mammary gland development through the action of
BMP signaling [25]. It plays a role in both growth and
apoptosis, particularly affecting the proliferative and re-
generative capacity of tissue [30]. FOXA2 plays a role in
mouse lung morphogenesis [31] as well as chicken
oviduct development [32], where it is modulated post-
transcriptionally by estrogen. It promotes epithelializa-
tion during embryogenesis [33] and has been shown to
directly [34] and indirectly [35] regulate E-cadherin
expression. Engrailed has been best characterized in the
Drosophila wing for its role as a segment polarity gene that
transcriptionally activates Hedgehog, which in turn estab-
lishes the Decapentaplegic (BMP homolog) morphogen
Table 1 Genes included in PCR array
Gene Function
Jun Fos and Jun dimerize to form AP-1,
involved in cell proliferation,
differentiation, and transformationFos
PCNA, proliferating cell nuclear
antigen
DNA synthesis, cell-cycle control, and
DNA-damage response and repair
CCND1, cyclin D1 Regulatory subunit of CDK4 or CDK6,






mycN Transcription factor amplified or
overexpressed in variety of tumors
cMYC Transcription factor activated upon
various mitogenic signals such as
Wnt, Shh and EGF
gli3 Transcription factor mediating sonic
hedgehog signaling
SOX2 Transcription factor with roles in
embryonic development, cell fate
determination, stem cell
maintenance
Oct4 Involved in the self-renewal of
undifferentiated embryonic
stem cells.
Klf4 Indicator of stem-like capacity in
embryonic stem cells
VEGF1 Endothelial cell mitogen
ANGPT1, angiopoietin 1 Involved in vascular development
and angiogenesis
CAV1, caveolin Scaffolding protein, possible tumor
suppressor
Wnt5A Secreted signaling protein, activates
beta catenin transcriptional activity
Wnt11 Secreted signaling protein,
implicated in oncogenesis and in
several developmental processes
SNAI2, snail2 Transcriptional repressor involved in
epithelial-mesenchymal transitions
and has antiapoptotic activity.
TGFbeta Member of a family of peptides that
regulate proliferation, differentiation,
adhesion, migration, and other
functions in many cell types
IGF1, insulin like growth factor Growth and anabolic effects
IL2 Cytokine regulates lymphocyte
activity
IL10 Anti-inflammatory cytokine
PTGS1, COX1, prostaglandin G/H
synthase and cyclooxygenase)
Converts arachidonic acid to
prostaglandin
Hales et al. BMC Genomics 2014, 15:709 Page 6 of 14
http://www.biomedcentral.com/1471-2164/15/709gradient [36]. In mammals, EN2 has been shown to be dys-
regulated in bladder, ovarian and prostate cancers, whereas
EN1 has been demonstrated in salivary gland adenoid cys-
tic carcinoma [37]. Interestingly, Engrailed can be secreted
as well as taken up by cells and urinary EN2 levels havebeen proposed as a marker for prostate cancer [38].
Although expression of these genes may suggest a cell or
tissue of origin for ovarian cancer, an alternative interpre-
tation may be the induction of a morphogenic process in
the ovary to which a plastic transformed cell responds.
Thus, EOC could conceivably develop in the ovary due to
the activation of morphogens responsible for glandular
differentiation acting on transformed cells. The parallel
patterns of expression we observe in these genes in tumors
from both control-fed and flax-fed hens suggests that
formation of EOC is mediated in part by aberrant activa-
tion of a developmental program which controls branching
morphogenesis, and that dietary flaxseed impedes or per-
turbs this program.
miR-200 family is upregulated in hen ovarian cancer
compared to normal ovaries and is decreased by
dietary flaxseed
It has been observed in human ovarian cancers that in-
creased E-cadherin parallels increased levels of miR-200
family members [39]. While the function of the miR-200
family in ovarian cancer is complex, this upregulation is
currently under rigorous scrutiny for potential diagnostic
and prognostic value. To date, the relationship between
E-cadherin and the three members of the chicken miR-
200 family has not been examined in chicken ovarian
cancer. We measured expression levels of miR-200a,
miR-200b, and miR-429 in ovarian tumors from control-
fed hens and found they were upregulated 22-fold,
26-fold, and 18-fold respectively, compared to expres-
sion levels in normal ovaries. Expression levels of miR-
200a, miR-200b and miR-429 were upregulated 5-fold,
7-fold, and 8-fold respectively, in ovarian tumors from
flax-fed hens compared to normal ovaries (Figure 7).
These data show that the chicken miR200 family is up-
regulated in ovarian tumors and that flaxseed was able
to significantly inhibit the up-regulation of all three
members in ovarian cancer by 55 to 80%. It has recently
been shown that miR200 family members can be in-
duced in ovarian cancer cells after exposure to oxidative
stress [40]. Flaxseed acts as an antioxidant, particularly
through the action of the lignan seicoisolariceresinol
diglucoside, and its metabolites enterodiol and en-
terolactone [41,42]. The action of these antioxidants
may account for the decreased levels of miR200 family
members in the flax-fed hens. Localization of miR-200a
by in situ hybridization shows that expression is con-
fined to the glandular epithelial compartment of the
ovarian tumor, reflecting the positive correlation bet-
ween miR-200 expression and E-cadherin expression in
hen ovarian cancer (Figure 7). Relatively few studies have
shown that dietary manipulation can directly affect
miRNA expression. A limited number of specific dietary
constituents and phytochemicals have been identified
Figure 4 Real Time-PCR gene expression analysis. Selected genes were analyzed by PCR-array to validate microarray data.
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motherapeutic action by modulation of miRNA expres-
sion or activity. The majority of these studies have
utilized in vitro culture systems to examine the effects of
dietary constituents on miRNA expression. The few
whole-animal studies that have been conducted have
shown promise in their abilities to modulate miRNAexpression [43]. This is the first report of dietary modu-
lation of microRNAs in a spontaneous cancer model.
It has been well-established that the level of E-cadherin
expression can reflect a balance between miR200 and
ZEB1 expression [44]. The 3′ untranslated region of ZEB1
mRNA has several binding sites for the miR200 family
and has been shown to be targeted for degradation by
Figure 5 PCR analysis of select genes shown to be differentially
expressed by microarray. MSX2, FOXA2, EN-1, PAX2 and E-cadherin
are significantly upregulated in ovarian cancer compared to normal
ovaries. This upregulation is attenuated in ovarian tumors from
flax-fed hens.
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both miR200 and E-cadherin [45-47]. We considered the
possibility that the decrease observed in both E-cadherin
and miR200 expression in tumors from flax-fed hens
reflected increased ZEB1 expression. Analysis of ZEB1
mRNA by qPCR indicated that there was already a sig-
nificant increase in ZEB1 mRNA in ovarian tumors from
control-fed hens compared to normal, and a similar in-
crease was observed in tumors from flax-fed hens com-
pared to normal ovaries (Figure 8). Interaction betweenmicroRNAs and their mRNA targets can be mediated by
degradation of the mRNA or by sequestration from trans-
lation. Immunohistochemistry was performed to deter-
mine if ZEB1 was expressed in the tumor epithelium.
Oviduct served as a positive control and no staining was
observed in normal ovary (Additional file 3). Immunohis-
tochemistry revealed that there were ZEB1 positive cells
in the normal stromal compartment (Figure 8, arrows)
adjacent to the tumors but not in the tumor epithelial
cells, nor in the stromal cells between the glandular tumor
epithelia. No difference in localization was observed bet-
ween tumors from control-fed and flax-fed hens. This
suggests that the effect of the flaxseed diet on E-cadherin
and miR200 in ovarian tumors in the chicken is not by
way of an epithelial-mesenchymal transition mechanism
caused by an increase in ZEB1 expression in the epithelial
compartment.
Dietary flaxseed significantly decreases expression of
miR-200 family in hen ovarian cancer, but does not affect
expression of miR-200 family in normal ovaries. This ob-
servation is significant in its implication that some of the
chemopreventive mechanisms of flaxseed function at the
epigenetic regulatory level. Indeed, whole flaxseed con-
tains elements that exert pleiotropic actions in cancer cells
by functioning as antioxidant, anti-inflammatory, and
anti-estrogenic agents.
Conclusions
Microarray analysis revealed that flaxseed downregulates
certain genes associated with ovarian cancer develop-
ment and progression, and that pathways known to be
dysregulated in ovarian cancer are targets of flaxseed ac-
tion. More importantly, these data support the idea that
dietary manipulation can modulate epigenetic and tran-
scriptional changes associated with cancer development
and progression. Notably, flax affects a group of genes in
tumors that control branching morphogenesis during
gland development, including PAX2, FOXA2, MSX2 and
EN1. Expression of these genes explains the glandular
appearance of the tumors and is evidence of the process
directing tumor growth, a process that involves pro-
liferation and subsequent differentiation into glands. The
upregulation of E-cadherin is a key feature of gland
development and in these tumors is paralleled by the ex-
pression of miR-200 family members. Flaxseed downre-
gulates all of these genes in a parallel fashion, suggesting
a coordinated regulation, and without inducing an
epithelial-mesenchymal transition; the epithelial mor-
phology is maintained. Recently, stem-like epithelial cells
have been identified in both ovarian surface epithelium
and the distal cells of the tubal fimbriae [48,49]. Induc-
tion of genes involved in glandular morphogenesis may
drive these stem cells to proliferate and differentiate into
the ovarian cortex in response to morphogens present in
Figure 6 Double fluorescent immunohistochemistry, Expression of PAX2 (row A), FOXA2 (row B) and EN-1 (row C) colocalize with
E-cadherin in glandular epithelial tumor cells. Only E-cadherin is expressed in normal ovarian tissue; PAX2, FOXA2 and EN-1 are not (data not
shown). Dietary flaxseed does not alter the spatial expression of these factors (data not shown).
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not completely eliminate, signals from the cortex that
are involved in the proliferative phase of the process of
branching morphogenesis, leaving the ability to differen-
tiate intact, thereby revealing molecular targets that will
provide the foundation for clinical intervention studies.
Methods
Reagents
Antibodies: E-cadherin (BD transduction laboratories),
PAX2 (Invitrogen), Dylight-488 donkey anti-mouse IgG,
Dylight-549 donkey anti-rabbit IgG and Alexafluor-549
donkey anti-mouse IgG (Jackson Immunoresearch), DAPI
fluorescent mounting medium (Southern Biotech). The
HNF3B (HC7) monoclonal antibody was developed by
Thomas Jessel and Susan Brenner-Morton and the
Engrailed-1 monoclonal antibody (4D9) was developed by
Corey Goodman. Both were obtained from the Develop-
mental Studies Hybridoma Bank developed under the aus-
pices of the NICHD and maintained by the University of
Iowa, Dept. of Biology, Iowa City, IA 52242.
Animal care and tissue collection
Single–comb White Leghorn hens were maintained as
previously described [14,50], with review and approval ofthe Institutional Animal Care and Use Committees at
the University of Illinois at Urbana-Champaign and
Southern Illinois University at Carbondale. The one year
study included 387 2.5 year old hens and the five year
study included 682 hens that aged 12–45 months. Hens
were randomly divided into Control and Flax groups,
where Control hens were fed a standard diet, while the
Flax group was fed a diet supplemented with 10% flax-
seed. Diet composition was previously described in detail
[14]. Upon necropsy, tissues were collected and pro-
cessed as described [14].
Total RNA extraction and analysis
Total RNA was extracted from ovarian tissue that was ei-
ther flash-frozen in liquid nitrogen, or stored in RNAlater
(Invitrogen Life Technologies, Gaithersburg, MD). TRIzol
reagent (Invitrogen) was used according to manufacturer′s
instructions. Quantification of RNA was done using
NanoDrop ND-1000 spectrophotometer measurement
(NanoDrop Technologies). Integrity of total RNA was
confirmed by Experion RNA StdSens Analysis (BioRad,
Inc.). Biological replicates used in the microarray analysis
were: 6 control normal replicates (C7,C8, C13, C22, C23,
C31), 6 control cancer replicates (C16, C21, C30, C35,
C60, C71), 6 flaxseed normal replicates (F1, F2, F5, F9,
Figure 7 qPCR analysis of miR-200 family and in situ hybridization of miR200a. Expression of all three members of the chicken miR-200
family is significantly upregulated in ovarian tumors compared to normal ovaries. Expression of all three members is significantly decreased in
ovarian tumors from flax-fed hens compared to tumors from control-fed hens. Expression of miR-200a is confined to the tumor cells of the
control-fed ovary (A) and flax-fed ovary (B). Little if any expression is observed in normal ovary tissue (C). Magnification 20x on left, 100x on right.
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http://www.biomedcentral.com/1471-2164/15/709F20, F32) and 6 flaxseed cancer replicates (F11, F32,
F36, F38, F86, F89) from the one year flaxseed study.
The cancer replicates were of similar grade, stage and
histotype.Labeling and hybridization
The microarray procedure was conducted at the University
of Illinois Urbana-Champaign at the Keck Center for
Biotechnology. One microgram of total RNA was labeled
Figure 8 ZEB1 mRNA and immunohistochemistry. qPCR of ZEB1 mRNA indicates an upregulation in tumors from both control and flax fed
hens but no nuclear expression by immunohistochemistry in the tumor epithelium (control-fed top, flax-fed bottom). Some nuclear expression is
seen in adjacent normal stroma from flax fed hen (bottom, arrows). ZEB1 is red, E-cadherin is green, nuclei are stained with DAPI. Smaller micrographs
include the blue DAPI channel. Magnification at 100x.
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http://www.biomedcentral.com/1471-2164/15/709using the Agilent two-color QuickAmp labeling kit
(Agilent Technologies) according to the manufacturer’s
protocol. Agilent custom 4x44K chicken long oligo micro-
array, designed by Dr. Zhou of Texas A&M University
was utilized for the array analysis [16]. Samples were
hybridized using the In situ hybridization kit plus (Agilent
Technologies, Palo Alto, CA, USA). Arrays were incu-
bated at 65°C for 17 hours in Agilent’s microarray hy-
bridization chambers. After hybridization, arrays were
washed according to the Agilent protocol. Arrays werescanned at 5-μm resolution using an Axon GenePix 4000B
scanner (Molecular Devices Corporation, Sunnyvale, CA)
and images were saved as TIFF format. Images were
quantified using Axon GenePix 6.0 (Molecular Devices
Corporation, Downingtown, PA), and data were saved
as .txt files for further analysis.
Data normalization and statistical analysis
Median foreground signal intensities (no background sub-
traction) were normalized using Locally Weighted Linear
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http://www.biomedcentral.com/1471-2164/15/709Regression (LOWESS) within the R statistics package (ver-
sion 2.7.2) using the “VSN” method in limma (version
2.14.7) to remove signal intensity-dependent dye bias.
Spots with −100 flags were weighted zero before
normalization. P value and fold changes between each
comparison for each gene were calculated. Microarray
data are MIAME compliant and available in Gene Expres-
sion Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/)
through the accession number GSE40376. Differentially
expressed genes were identified by setting the significance
level to a false discovery rate of <0.1.
Bioinformatic analysis
Annotations were done using Database for Annotation,
Visualization and Integrated Discovery (DAVID) tool
[51,52]. We applied various bioinformatics tools such as
Multiple Experimental Viewer for the heatmap [53], and
Ingenuity Pathway Analysis (Ingenuity® Systems, www.
ingenuity.com). Functional classification of these genes
was carried out using the gene expression analysis tool
PANTHER (Protein ANalysis THrough Evolutionary
Relationships) [54,55] and Gene Ontology Enrichment
Analysis Software Toolkit [56] for analysis.
Microarray data sorting and gene expression analysis
Comparing the gene expression levels of the groups, the
threshold level was set at >2 and <2 fold differences for
the analysis. Differentially expressed genes in control-
cancer vs. control-normal (CC-CN) and flax-cancer vs.
flax-normal (FC-FN) constituted primary gene dataset.
Then these primary datasets of CC-CN and FC-FN were
compared which resulted in a secondary dataset consisting
of 324 common and 287 uncommon genes of these two
groups. The common genes signify that these genes are
crucial in cancer progression and unaffected by flaxseed,
whereas uncommon genes present in CC-CN group may
be possible targets of flaxseed. To identify these potential
flaxseed target genes, the uncommon genes in CC-CN were
compared with flax-normal vs control-normal (FN-CN)
dataset which generated a final list of 118 common genes.
PCR-array
Four biological replicate samples from control-normal,
control-cancer, flax-normal and flax-cancer were used
for analysis. Total RNA was transcribed into cDNA
using qScript DNA supermix. A customized 384 well
StellARray (Cat#00194810) for Gallus gallus was pur-
chased from Bar Harbor BioTechnology. A total of 44
target genes (including 4 housekeeping genes) were se-
lected for analysis. Real-time PCR was performed using
cDNA and EvaGeen mix (BioRad, Inc.) in a 384 well plate
with primer mix for selected genes. The reaction and sig-
nal were measured using BioRad CFX manager software
(BioRad Inc.). The expression levels were calculated asrelative expression normalized to the expression levels of
the housekeeping genes TATA box binding protein 1
(TBP1), Ribosomal protein L4 (RPL4), Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and Succinate
dehydrogenase complex, subunit A (SDHA).
cDNA Synthesis and qPCR analysis of mRNA Targets
First-strand cDNA synthesis was performed using total
RNA and qScript cDNA Supermix (Quanta Biosciences
95048) according to manufacturer’s instructions. qPCR
was performed using SsoFast EvaGreen Supermix (BioRad
172–5203). Reactions were 10ul and used 400 nm sym-
metric primer mix. Amplification conditions were as fol-
lows: 95C 5 s, 40 cycles for 95C 5 s, 58-68C 2 s.
Expression analysis was performed using BioRad CFX
Manager Software. mRNA levels were normalized to two
stably expressed reference genes, SDHA and RPL4.
Double-fluorescent Immunohistochemistry
Ovary tissue was collected from hens in the five year
study, processed, fixed in NBF and paraffin-embedded as
previously described [50]. Five micrometer sections were
mounted onto charged Superfrost slides, deparaffined in
xylene and rehydrated in graded ethanol solutions. Anti-
gen retrieval was performed by heating slides under pres-
sure of 15 psi in 0.1 M sodium citrate for 20 minutes.
Slides were blocked with phosphate buffered saline/0.1%
Tween-20 (PBST) and 5% fetal calf serum for 2 hours.
Following blocking, sections stained for PAX2 and
E-cadherin were incubated overnight with both rabbit
anti-mouse PAX2 at 1:200 and mouse anti-human E-
cadherin at 1:500 in PBST with 5% fetal calf serum. Slides
were washed in PBST and incubated with both Dylight-
488 donkey anti-mouse IgG and Dylight-549 donkey
anti-rabbit IgG) at 1:200 for 2 hours. Sections stained for
E-cadherin/EN-1 and E-cadherin/FOXA2 were incubated
with anti- E-cadherin overnight, washed in PBST and then
incubated with Alexafluor-549 donkey anti-mouse IgG at
1:200 for 2 hours. A second overnight incubation with
either anti-HNF3beta or anti-Engrailed-1 at 1:10 in PBST
and 5% fetal calf serum, followed by incubation with
Dylight 488-conjugated donkey anti-mouse IgG at 1:200
for 2 hours completed the double-labeling. All slides were
mounted with DAPI fluorescent mounting medium and
visualized by confocal microscopy using a Leica model
DM5500Q microscope using filters A4, Y5,and L5, and
images were captured with a Leica DFC365 FX camera.
Dual images were produced using Leica Application
Suite-Advanced fluorescence version 2.6.0.7266.
miRNA quantification
Total RNA was isolated from flash-frozen ovary tissue from
the five year study using Tri Reagent (Ambion). First-strand
cDNA synthesis was performed using Universal cDNA
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quantified using SYBR Green master mix, Universal RT kit
(Exiqon 203420). Locked nucleic acid primers for miR-200a
(Exiqon 204707), miR-200b (custom Exiqon primer set),
and miR-429 (Exiqon 205068) were used for quantification.
qPCR values were normalized to two reference miRNAs
stably expressed across the sample population, miR-460
(Exiqon) and miR-455 (Exiqon). Six samples were analyzed
per group. Statistical analysis using one-way ANOVA
followed by Student–Newman-Keuls post test was per-
formed using GraphPad Instat program. p values of 0.05 or
less were considered significant.
miRNA in situ hybridization
In situ hybridization for miR-200a was performed as pre-
viously described [57] with modifications. Briefly, formalin-
fixed, paraffin-embedded tissues from the five year study
were sectioned at 5 micrometers and mounted onto
positively-charged Superfrost slides. Sections were depa-
raffined in Histoclear and rehydrated through graded etha-
nol solutions. Sections were then digested with proteinase
K (20ug/ml for 15 minutes) and acetylated. miR-200a
double-DIG-labeled LNA probe (Exiqon) was diluted to
20 nM in hybridization buffer (Roche) and sections were
hybridized overnight at 54°C. Following stringency washes,
sections were blocked and incubated with goat anti-digoxin
antibody conjugated to AP at 1:500 for 16 hours. Color
development was performed using BCIP/NBT (Roche) in
NTMT, 10% PVA and Levamisole (Sigma) for 30 hours.
Sections were counterstained with nuclear fast red and
mounted for visualization using a Leica model DM IL
microscope and DFC 400 camera.
Availability of supporting data
Microarray data are MIAME compliant and available in
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/) through the accession number GSE40376.Additional files
Additional file 1: Relative expression of 337 genes related to the
pathogenesis of ovarian cancer in pair-wise comparisons. aCCvsCN—
control cancer vs control normal. bFCvsCN—flax cancer vs control normal.
cFCvsCC–flax cancer vs control cancer. dFCvsFN—flax cancer vs flax normal.
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Additional file 2: 118 flaxseed-responsive genes involved in ovarian
cancer. aCC-CN– control-cancer vs. control-normal.
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expression of E-cadherin (green) in epithelium and ZEB1 (red) in
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in normal ovary. Nuclei are stained with DAPI.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DBH conceived of and designed the microarray study, NKK performed the
bioinformatic analysis of the microarray and PCR array, KHH assisted in the
design of the PCR array, SCS carried out the PCR analysis of miRNAs and
mRNAs and performed the in situ hybridization and immunohistochemistry.
All four authors helped to draft and revise the manuscript and have read
and approved the final version.
Acknowledgements
We wish to thank Dr. Sharon Stack for her critical reading of the manuscript,
and Stacey McGee for the Zeb1 immunohistochemistry.
This work was supported by NIH/NCCAM AT005295 (DBH), NIH/NCCAM
AT004085 (DBH); NIH/NCI CA133915 (DBH), Art Erhmann Cancer Fund,
Fraternal Order of Eagles (KHH) and startup funds from Southern Illinois
University School of Medicine (KHH).
Author details
1Department of Obstetrics and Gynecology, Southern Illinois University at
Carbondale, School of Medicine, Life Science III, (M/C 6512), 1135 Dr.,
Carbondale, Lincoln, IL 62901, USA. 2Department of Physiology, Southern
Illinois University at Carbondale, School of Medicine, Life Science III, (M/C
6512), 1135 Dr., Carbondale, Lincoln, IL 62901, USA. 3Current address CSIR
Central Food Technological Research Institute, Mysore, KA 570020, India.
Received: 27 November 2013 Accepted: 5 June 2014
Published: 24 August 2014
References
1. Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD,
Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, Friedlander M,
Gabra H, Kaye SB, Lord CJ, Lengyel E, Levine DA, McNeish IA, Menon U,
Mills GB, Nephew KP, Oza AM, Sood AK, Stronach EA, Walczak H,
Bowtell DD, Balkwill FR: Rethinking ovarian cancer: recommendations
for improving outcomes. Nat Rev Cancer 2011, 11(10):719–725.
2. Wiseman M: The second world cancer research fund/American
institute for cancer research expert report. Food, nutrition, physical
activity, and the prevention of cancer: a global perspective. Proc Nutr
Soc 2008, 67(03):253–256.
3. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002, 420(6917):860–867.
4. Wang L-Q: Mammalian phytoestrogens: enterodiol and enterolactone.
J Chromatogr B 2002, 777(1–2):289–309.
5. Johnson PA, Giles JR: The hen as a model of ovarian cancer. Nat Rev
Cancer 2013, 13(6):432–436.
6. Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP,
Hales DB, Stack MS: Epithelial ovarian cancer experimental models.
Oncogene 2013. August 12 [Epub ahead of print].
7. Fredrickson TN: Ovarian tumors of the hen. Environ Health Perspect 1987,
73:35–51.
8. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric
MJ, Edassery SL, Rotmensch J, Luborsky JL: Histopathology of ovarian
tumors in laying hens: a preclinical model of human ovarian cancer.
Int J Gynecol Cancer 2009, 19(4):531–539.
9. Hakim AA, Barry CP, Barnes HJ, Anderson KE, Petitte J, Whitaker R,
Lancaster JM, Wenham RM, Carver DK, Turbov J, Berchuck A, Kopelovich
L, Rodriguez GC: Ovarian adenocarcinomas in the laying hen and
women share similar alterations in p53, ras, and HER-2/neu. Cancer
Prev Res (Phila) 2009, 2(2):114–121.
10. Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE: CA125
expression in spontaneous ovarian adenocarcinomas from laying
hens. Gynecol Oncol 2007, 104(1):192–198.
11. Zhuge Y, Lagman JA, Ansenberger K, Mahon CJ, Daikoku T, Dey SK, Bahr JM, Hales
DB: CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus.
Gynecol Oncol 2009, 112(1):171–178.
12. Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, Bahr JM,
Hales DB: E-cadherin expression in ovarian cancer in the laying hen,
Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol
2009, 113(3):362–369.
Hales et al. BMC Genomics 2014, 15:709 Page 14 of 14
http://www.biomedcentral.com/1471-2164/15/70913. Hales DB, Zhuge Y, Lagman JA, Ansenberger K, Mahon C, Barua A, Luborsky
JL, Bahr JM: Cyclooxygenases expression and distribution in the normal
ovary and their role in ovarian cancer in the domestic hen (Gallus
domesticus). Endocrine 2008, 33(3):235–244.
14. Ansenberger K, Richards C, Zhuge Y, Barua A, Bahr JM, Luborsky JL, Hales DB:
Decreased severity of ovarian cancer and increased survival in hens fed a
flaxseed-enriched diet for 1 year. Gynecol Oncol 2010, 117(2):341–347.
15. Eilati E, Bahr JM, Hales DB: Long term consumption of flaxseed enriched
diet decreased ovarian cancer incidence and prostaglandin E2 in hens.
Gynecol Oncol 2013, 130(3):620–628.
16. Li X, Chiang HI, Zhu J, Dowd SE, Zhou H: Characterization of a newly
developed chicken 44 K Agilent microarray. BMC Genomics 2008, 9:60.
17. Landen CN Jr, Birrer MJ, Sood AK: Early events in the pathogenesis of
epithelial ovarian cancer. J Clin Oncol 2008, 26(6):995–1005.
18. Zhang J, Chen YH, Lu Q: Pro-oncogenic and anti-oncogenic pathways:
opportunities and challenges of cancer therapy. Future Oncol 2010,
6(4):587–603.
19. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation.
Cell 2011, 144(5):646–674.
20. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from
mouse embryonic and adult fibroblast cultures by defined factors.
Cell 2006, 126(4):663–676.
21. Hudson LG, Zeineldin R, Stack MS: Phenotypic plasticity of neoplastic
ovarian epithelium: unique cadherin profiles in tumor progression.
Clin Exp Metastasis 2008, 25(6):643–655.
22. Ansenberger K: The Laying hen and Flaxseed: A Model for Dietary Intervention
of Human Ovarian Cancer. Ph.D. Chicago: University of Illinois at Chicago,
Health Sciences Center; 2010.
23. Torres M, Gomez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple
steps of urogenital development. Development 1995, 121(12):4057–4065.
24. Bazer FW: Uterine adenogenesis and pregnancy: multiple roles for Foxa2
in mice. Biol Reprod 2010, 83(3):319–321.
25. Satoh K, Ginsburg E, Vonderhaar BK: Msx-1 and Msx-2 in mammary gland
development. J Mammary Gland Biol Neoplasia 2004, 9(2):195–205.
26. Logan C, Hornbruch A, Campbell I, Lumsden A: The role of Engrailed in
establishing the dorsoventral axis of the chick limb. Development 1997,
124(12):2317–2324.
27. Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A,
Wolf JK, Lu KH, Gershenson DM, Wong KK: PAX2 expression in low malignant
potential ovarian tumors and low-grade ovarian serous carcinomas.
Mod Pathol 2009, 22(9):1243–1250.
28. Trevino LS, Giles JR, Wang W, Urick ME, Johnson PA: Gene expression
profiling reveals differentially expressed genes in ovarian cancer
of the hen: support for oviductal origin? Horm Cancer 2010, 1(4):177–186.
29. Zhai Y, Iura A, Yeasmin S, Wiese AB, Wu R, Feng Y, Fearon ER, Cho KR:
MSX2 is an oncogenic downstream target of activated WNT signaling
in ovarian endometrioid adenocarcinoma. Oncogene 2011,
30(40):4152–4162.
30. Bendall AJ, Abate-Shen C: Roles for Msx and Dlx homeoproteins in
vertebrate development. Gene 2000, 247(1–2):17–31.
31. Wan H, Dingle S, Xu Y, Besnard V, Kaestner KH, Ang S-L, Wert S, Stahlman
MT, Whitsett JA: Compensatory Roles of Foxa1 and Foxa2 during Lung
Morphogenesis. J Biol Chem 2005, 280(14):13809–13816.
32. Berger RR, Sanders MM: Estrogen modulates HNF-3beta mRNA levels in
the developing chick oviduct. DNA Cell Biol 2000, 19(2):103–112.
33. Burtscher I, Lickert H: Foxa2 regulates polarity and epithelialization in
the endoderm germ layer of the mouse embryo. Development 2009,
136(6):1029–1038.
34. Liu Y-N, Lee W-W, Wang C-Y, Chao T-H, Chen Y, Chen JH: Regulatory
mechanisms controlling human E-cadherin gene expression.
Oncogene 2005, 24(56):8277–8290.
35. Song Y, Washington MK, Crawford HC: Loss of FOXA1/2 is essential for the
epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res
2010, 70(5):2115–2125.
36. Hidalgo A: Growth and patterning from the engrailed interface. Int J Dev
Biol 1998, 42(3):317–324.
37. McGrath SE, Michael A, Pandha H, Morgan R: Engrailed homeobox
transcription factors as potential markers and targets in cancer. FEBS
Lett 2013, 587(6):549–554.
38. Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, Whitaker HC,
Neal DE, Ismail M, Whitaker H, Annels N, Michael A, Pandha H: Engrailed-2(EN2): a tumor specific urinary biomarker for the early diagnosis of
prostate cancer. Clin Cancer Res 2011, 17(5):1090–1098.
39. van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA: MicroRNAs in
ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol
2010, 42(8):1282–1290.
40. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O,
Nicolas A, Meyniel J-P, Cottu P, Sastre-Garau X, Mechta-Grigoriou F:
miR-141 and miR-200a act on ovarian tumorigenesis by controlling
oxidative stress response. Nat Med 2011, 17(12):1627–1635.
41. Prasad K: Antioxidant activity of secoisolariciresinol diglucoside-derived
metabolites, secoisolariciresinol, Enterodiol, and enterolactone. Int J
Angiol 2000, 9(4):220–225.
42. Kivelä AM, Kansanen E, Jyrkkänen H-K, Nurmi T, Ylä-Herttuala S,
Levonen A-L: Enterolactone induces heme oxygenase-1 expression
through nuclear factor-E2-related factor 2 activation in endothelial
cells. J Nutr 2008, 138(7):1263–1268.
43. Parasramka MA, Ho E, Williams DE, Dashwood RH: MicroRNAs, diet, and
cancer: new mechanistic insights on the epigenetic actions of
phytochemicals. Mol Carcinog 2012, 51(3):213–230.
44. Cano A, Nieto MA: Non-coding RNAs take centre stage in epithelial-to-
mesenchymal transition. Trends Cell Biol 2008, 18(8):357–359.
45. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S,
Brabletz T: A reciprocal repression between ZEB1 and members of
the miR-200 family promotes EMT and invasion in cancer cells. EMBO
Rep 2008, 9(6):582–589.
46. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G,
Vadas MA, Khew-Goodall Y, Goodall GJ: The miR-200 family and
miR-205 regulate epithelial to mesenchymal transition by targeting
ZEB1 and SIP1. Nat Cell Biol 2008, 10(5):593–601.
47. Park SM, Gaur AB, Lengyel E, Peter ME: The miR-200 family determines the
epithelial phenotype of cancer cells by targeting the E-cadherin repressors
ZEB1 and ZEB2. Genes Dev 2008, 22(7):894–907.
48. Auersperg N: The stem-cell profile of ovarian surface epithelium is
reproduced in the oviductal fimbriae, with increased stem-cell
marker density in distal parts of the fimbriae. Int J Gynecol Pathol
2013, 32(5):444–453.
49. Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D,
Huang J, Witte ON, Memarzadeh S: Stem-like epithelial cells are
concentrated in the distal end of the fallopian tube: a site for injury and
serous cancer initiation. Stem Cells 2012, 30(11):2487–2497.
50. Eilati E, Pan L, Bahr JM, Hales DB: Age dependent increase in prostaglandin
pathway coincides with onset of ovarian cancer in laying hens.
Prostaglandins Leukot Essent Fatty Acids 2012, 87(6):177–184.
51. da Huang W, Sherman BT, Lempicki RA: Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources.
Nat Protoc 2009, 4(1):44–57.
52. da Huang W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists.
Nucleic Acids Res 2009, 37(1):1–13.
53. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M,
Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov
A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J:
TM4: a free, open-source system for microarray data management and
analysis. Biotechniques 2003, 34(2):374–378.
54. Mi H, Thomas P: PANTHER pathway: an ontology-based pathway database
coupled with data analysis tools. Methods Mol Biol 2009, 563:123–140.
55. Mi H, Muruganujan A, Casagrande JT, Thomas PD: Large-scale gene
function analysis with the PANTHER classification system. Nat Protoc
2013, 8(8):1551–1566.
56. Zheng Q, Wang XJ: GOEAST: a web-based software toolkit for
Gene Ontology enrichment analysis. Nucleic Acids Res 2008,
36(Web Server issue):W358–W363.
57. Bany B, Simmons D: Non-Radioactive in Situ Hybridizaion: Optimization for
Tissue Sections from Pregnant Uteri and Placenta During the First Half of
Pregnancy. In The Guide for Investigation of Mouse Pregnancy. Edited by Croy B,
Yamada A, DeMayo F, Adamson S. Amsterdam: Elsevier; 2013:591–603.
doi:10.1186/1471-2164-15-709
Cite this article as: Hales et al.: Uncovering molecular events associated
with the chemosuppressive effects of flaxseed: a microarray analysis of the
laying hen model of ovarian cancer. BMC Genomics 2014 15:709.
